Tartary Buckwheat (Fagopyrum tataricum)

Fagopyrum tataricum
Evidence Level
Limited
6 Clinical Trials
7 Documented Benefits
2/5 Evidence Score

Tartary buckwheat (Fagopyrum tataricum), also called bitter buckwheat, is a separate species from common buckwheat (Fagopyrum esculentum). Its seeds are eaten as flour, noodles, cooked grain and roasted grain tea, and hold much more rutin than common buckwheat, about 0.8 to 1.7 percent of dry weight against about 0.01 percent, but a seed enzyme turns much of that rutin into bitter quercetin within minutes of adding water. In small, short trials in adults with type 2 diabetes, tartary buckwheat foods in place of some rice or wheat lowered total and LDL cholesterol, fasting insulin and urine albumin more than diet advice alone, while blood sugar and HbA1c did not differ. High-rutin cookies lowered one inflammation marker versus common buckwheat cookies. A pooled analysis of buckwheat trials found no significant change in cholesterol or glucose. Buckwheat can cause severe allergic reactions.

Studied Dose About 100 g a day of tartary buckwheat noodles, cooked grain or powder in place of part of the rice or wheat for 4 weeks (average 114 g a day); four cookies (about 62 g) giving about 360 mg rutin equivalents a day for 2 weeks.
Active Compound Whole seed of Fagopyrum tataricum, eaten as flour, noodles, cooked grain or roasted grain tea. The seeds carry rutin (quercetin-3-O-rutinoside) at about 0.8 to 1.7 percent of dry weight, with traces of quercetin and quercitrin, plus protein, fiber and D-chiro-inositol in the bran. In one trial, four tartary buckwheat cookies supplied about 360 mg rutin equivalents a day, against about 17 mg from common buckwheat cookies.

Benefits

Blood cholesterol with daily tartary buckwheat foods

In adults with type 2 diabetes, replacing part of daily rice or wheat with tartary buckwheat foods for 4 weeks lowered total and LDL cholesterol more than diet advice alone in an open-label trial. In healthy women, cholesterol fell over 4 weeks of buckwheat cookies, with no difference between tartary and common buckwheat cookies and no buckwheat-free control, and HDL fell as well.

Fasting insulin and blood sugar with daily tartary buckwheat foods

In the same 4-week open-label trial in adults with type 2 diabetes, fasting insulin fell more than with diet advice alone, but fasting glucose and HbA1c did not differ, and insulin resistance improved only in people eating more than 110 g a day. A companion 4-week trial also found no difference in glucose, HbA1c or glycated albumin.

Blood sugar after a tartary buckwheat flour breakfast

In 43 adults with overweight or obesity, a breakfast of tartary buckwheat flour with an egg gave the highest 2-hour blood glucose and the widest glucose swings of five grain powders. The powders were eaten in a fixed order and differed in carbohydrate and protein, so this one-meal marker test cannot isolate the flour's own effect.

Myeloperoxidase, an inflammation marker, with high-rutin cookies

In 62 women, two weeks of tartary buckwheat cookies (about 360 mg rutin equivalents a day) lowered serum myeloperoxidase by about 16 percent compared with common buckwheat cookies (about 17 mg). C-reactive protein, other inflammation markers, lung function and breathlessness did not differ. This is one blood marker from one short trial.

Body weight in a 12-week trial of a rutin-rich variety

In 144 adults, foods made with a rutin-rich, low-bitterness tartary buckwheat variety gave lower body weight, BMI and a lipid oxidation marker than placebo foods at week 8, and lower body fat at week 4. Oxidized LDL and an atherosclerosis index did not differ, and a later review reported no effect on BMI or body fat by week 12.

Urine albumin and urea nitrogen in a 4-week staple food swap

In 104 adults with type 2 diabetes and an estimated filtration rate of at least 90, replacing part of daily rice or wheat with tartary buckwheat foods lowered the urine albumin to creatinine ratio and blood urea nitrogen more than diet advice alone. Creatinine, uric acid, filtration rate and blood pressure did not differ. The trial was open-label and lasted 4 weeks.

Rutin content compared with common buckwheat

Tartary buckwheat seeds held about 0.8 to 1.7 percent rutin by dry weight, against about 0.01 percent in common buckwheat. A seed enzyme, rutinosidase, breaks rutin down to bitter quercetin within minutes of adding water, so doughs can lose most of it; low-enzyme varieties such as Manten-Kirari keep more rutin and taste less bitter.

Mechanism of action

1

Rutin and its breakdown to quercetin in food

Rutin is quercetin bound to a sugar. In wet tartary buckwheat flour, the seed's own rutinosidase splits rutin into quercetin, the main source of the bitter taste, and dough from a normal variety lost all its rutin within 10 minutes. The cookie trial authors linked the lower myeloperoxidase to rutin intake, which has not been confirmed.

2

D-chiro-inositol in the bran (animal work)

Tartary buckwheat bran contains D-chiro-inositol, a compound involved in insulin signaling. An extract enriched in it lowered blood glucose, C-peptide and triglycerides and improved glucose tolerance in diabetic mice. How much D-chiro-inositol whole tartary buckwheat foods deliver, and whether it matters in people, has not been tested.

3

Protein and fiber in a staple food swap

The tartary buckwheat noodles, grain and powder in the Chinese kidney-marker trial supplied about 13 to 14 g protein and 6 to 8 g fiber per 100 g, and protein intake rose in the buckwheat group only. The comparison with rice or wheat was matched for energy but not for protein, so the results cannot be assigned to rutin or any single component.

4

Antioxidant activity of roasted grain tea (lab work)

In test-tube work, tartary buckwheat roasted at 210 C and brewed at room temperature for 24 hours gave the highest polyphenol and flavonoid content and radical-scavenging activity of four tea preparations, with rutin as the main contributor. These are chemical assays; tartary buckwheat tea has not been tested for antioxidant effects in people.

Clinical trials

1
Tartary Versus Common Buckwheat Cookies: Myeloperoxidase and Cholesterol
PubMed

Double-blind crossover trial with allocation by day-care center; four cookies a day for 2 weeks each, switched without washout. Tartary buckwheat cookies (about 62 g, 359.7 mg rutin equivalents a day) were compared with common buckwheat cookies of the same recipe (about 61 g, 16.5 mg); no buckwheat-free control; authors declared no conflicts and no funding source is stated (Wieslander et al. 2011, Tohoku J Exp Med)

62 female day-care center staff in Uppsala, Sweden, mean age 46, mean BMI 25.5.

Serum myeloperoxidase was lower on tartary buckwheat cookies than on common buckwheat cookies (0.84 times, 95 percent CI 0.73 to 0.97, p = 0.02). sPLA2, C-reactive protein, eosinophilic cationic protein, exhaled nitric oxide, FEV1, peak flow and breathlessness did not differ. Total and HDL cholesterol fell over 4 weeks with both cookie types and vital capacity rose 5 percent, but without a buckwheat-free control these changes cannot be attributed to buckwheat.

2
Tartary Buckwheat Staple Swap for 4 Weeks: Insulin and Blood Lipids
PubMed

Parallel, randomized, open-label controlled trial; part of the daily staple food replaced with tartary buckwheat foods for 4 weeks versus systematic diet plans and intensive nutrition education; funding and registration not given in the abstract (Qiu et al. 2016, Nutr Res)

165 adults with type 2 diabetes in China.

Compared with the diet-advice group, fasting insulin, total cholesterol (5.08 to 4.79 mmol/L) and LDL cholesterol (3.00 to 2.80 mmol/L) fell more in the buckwheat group (P < .05). Blood glucose and HbA1c did not differ between groups. Insulin resistance fell only in a subgroup eating more than 110 g a day.

3
Tartary Buckwheat Staple Swap for 4 Weeks: Urine Albumin and Kidney Markers
PubMed

Parallel, randomized, open-label controlled trial registered ChiCTR-IIR-15007600; about 100 g a day of energy-matched tartary buckwheat noodles, cooked grain or powder (supplied free by Guiyang Winner Hi-Tech Development Co.) in place of part of the rice or wheat, versus rice or wheat; both groups had weekly nutrition education; publicly funded (Qiu et al. 2016, Ther Clin Risk Manag)

104 adults with type 2 diabetes for 5 to 20 years and eGFR of at least 90, mean age about 59; most were taking glucose-lowering drugs.

The urine albumin to creatinine ratio (p = 0.032) and blood urea nitrogen (p = 0.028) fell more than in the control group. Serum creatinine, uric acid, eGFR, blood pressure, fasting glucose, HbA1c and glycated albumin did not differ. Average buckwheat intake was 114 g a day, and protein intake rose in the buckwheat group only.

4
Rutin-Rich Manten-Kirari Foods for 12 Weeks: Body Weight and Arterial Markers
PubMed

Randomized, double-blind, placebo-controlled trial of products made with the low-bitterness, rutin-rich variety Manten-Kirari against placebo foods for 12 weeks, with measurements again 3 weeks after stopping; read from the abstract only; Crossref lists funding from a NARO (Japan) health-food development program, and four co-authors are NARO researchers from the team that developed Manten-Kirari; not indexed in PubMed (Nishimura et al. 2016, J Funct Foods)

144 adults in Japan.

The atherosclerosis index and oxidized LDL did not differ between groups. Body weight, BMI and TBARS, a lipid oxidation marker, were lower than placebo at week 8, and body fat percentage at week 4 (p = 0.038). A 2022 systematic review reported no effect on BMI or body fat, and no lasting change in oxidized LDL or TBARS, at the end of the 12 weeks.

5
Tartary Buckwheat Flour Breakfast: Single-Meal Glucose Test Against Four Other Grain Powders
PubMed

Within-subject, fixed-sequence study; each of five commercial grain powders eaten for 3 days as breakfast with a boiled egg under continuous glucose monitoring, tartary buckwheat first; meals not matched for carbohydrate or energy; authors declared no commercial conflicts (Wang et al. 2026, Front Nutr)

43 adults with overweight or obesity in Shanxi, China.

The tartary buckwheat meal (13.5 g carbohydrate) gave the highest 2-hour blood glucose and the largest glucose variability of the five powders; its incremental glucose area was similar to millet and oat and higher than soy milk powder. A 5-minute bout of exercise after breakfast did not change its glucose response. This is a marker test of single meals.

6
Multi-Ingredient Capsule Based on Tartary Buckwheat: Single-Arm Epigenetic Study
PubMed

Single-arm, open-label 90-day study registered NCT05234203; four capsules a day of HTB Rejuvenate, containing 190 mg tartary buckwheat flour with 1,158 mg polyphenols (mainly quercetin), 300 mg D-chiro-inositol, 2-HOBA, HMB and other ingredients; no placebo; funded by the maker, Big Bold Health, which employed two authors (Perlmutter et al. 2024, Front Nutr)

50 healthy adults aged 18 to 85; 40 in the final analysis.

Changes in several epigenetic age clocks, estimated immune cell types and gene pathways were reported from before to after the 90 days. Without a control group, and with other ingredients far exceeding the buckwheat flour, these results do not show an effect of tartary buckwheat.

Side effects and drug interactions

Common Potential side effects

Buckwheat can cause IgE-mediated allergy, including severe reactions and anaphylaxis, from eating it, handling the flour at work or sleeping on buckwheat husk pillows. Allergenic proteins have been identified in tartary as well as common buckwheat. Anyone allergic to buckwheat should avoid tartary buckwheat foods, teas and extracts.
Cross-reactivity between buckwheat and peanut, latex, coconut, quinoa and poppy seed has been described, so people with those allergies should be cautious.
The human trials lasted 2 to 12 weeks, so longer-term data in people are lacking. In rats, dough from a rutin-rich tartary buckwheat variety caused no toxic effects at 5,000 mg of flour per kg of body weight in a subacute study.
Tartary buckwheat flour tastes strongly bitter once wetted, because a seed enzyme breaks down its rutin.

Important Drug interactions

Glucose-lowering medication: in two 4-week trials in adults with type 2 diabetes, most of whom took glucose-lowering drugs, blood glucose and HbA1c did not differ from diet advice alone. No interaction study has been done, so check with your doctor before making large diet changes.
Concentrated rutin and quercetin: extracts and blends can deliver far more of these flavonoids than the food. Quercetin has altered blood levels of some medicines in human studies; see the rutin and quercetin pages and ask a pharmacist.
No drug interaction studies of tartary buckwheat foods or extracts have been published. Tell your doctor or pharmacist about any supplement you take.

Frequently asked questions about Tartary Buckwheat (Fagopyrum tataricum)

What is tartary buckwheat?

Tartary buckwheat (Fagopyrum tataricum), also called bitter buckwheat, is one of the two main cultivated buckwheat species. It is eaten as flour, noodles, cooked grain and roasted grain tea. Its seeds hold much more rutin than common buckwheat, and the flour turns bitter when wetted because a seed enzyme breaks the rutin down to quercetin.

How is tartary buckwheat different from common buckwheat and buckwheat sprouts?

Common buckwheat (Fagopyrum esculentum) is the more widely grown species. Tartary buckwheat seeds measured about 0.8 to 1.7 percent rutin by dry weight against about 0.01 percent for common buckwheat, and had less protein in one field comparison. Buckwheat sprouts are germinated seedlings, a separate product with no human trials of their own; the tartary buckwheat trials used the mature seed as flour, grain, noodles or cookies.

How much tartary buckwheat was used in studies?

Chinese trials replaced part of the daily rice or wheat with about 100 g a day of tartary buckwheat noodles, cooked grain or powder for 4 weeks. A Swedish trial used four cookies a day, about 62 g, giving about 360 mg rutin equivalents. No dose of a tartary buckwheat extract has been tested in a controlled trial, so follow the product label.

Is a tartary buckwheat supplement the same as the foods that were studied?

Not necessarily. The trials used whole flour, noodles, grain or cookies. A capsule blend described as based on tartary buckwheat contained only 190 mg of the flour a day, with much larger amounts of quercetin, D-chiro-inositol and other ingredients, and it was tested without a placebo. Check the label for how much tartary buckwheat a product actually contains.

Is tartary buckwheat safe?

It has been eaten as a food in trials of up to 12 weeks, but longer-term data in people are lacking. The main risk is buckwheat allergy, which can cause anaphylaxis, and cross-reactions with peanut, quinoa, coconut, poppy seed and latex have been described. If you take glucose-lowering or other prescription drugs, talk to your doctor before using concentrated extracts.

What is Tartary Buckwheat used for?

NutraSmarts does not list Tartary Buckwheat under a health category. What the research covers: In adults with type 2 diabetes, replacing part of daily rice or wheat with tartary buckwheat foods for 4 weeks lowered total and LDL cholesterol more than diet advice alone in an open-label trial.

Does Tartary Buckwheat interact with any medications?

Possible interactions include: Glucose-lowering medication: in two 4-week trials in adults with type 2 diabetes, most of whom took glucose-lowering drugs, blood glucose and HbA1c did not differ from diet advice alone. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Tartary Buckwheat?

NutraSmarts rates the evidence for Tartary Buckwheat as Limited (2 out of 5). It is backed by 6 study summaries and 16 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(16 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Wieslander G, Fabjan N, Vogrincic M, Kreft I, Janson C, Spetz-Nyström U, Vombergar B, Tagesson C, Leanderson P, Norbäck D. Eating buckwheat cookies is associated with the reduction in serum levels of myeloperoxidase and cholesterol: a double blind crossover study in day-care centre staffs. Tohoku J Exp Med. 2011;225(2):123-30. doi: 10.1620/tjem.225.123.PubMedUsed to support: Double-blind crossover trial in 62 female day-care staff in Uppsala, Sweden, allocated by day-care center (two centers versus three). Each group ate four cookies a day for 2 weeks and then switched, with no washout: tartary buckwheat cookies (about 62 g, 359.7 mg rutin equivalents a day) or common buckwheat cookies of the same recipe (about 61 g, 16.5 mg). Serum myeloperoxidase was lower on tartary cookies (0.84 times, 95 percent CI 0.73 to 0.97, p = 0.02); sPLA2, C-reactive protein, eosinophilic cationic protein, exhaled nitric oxide, FEV1, peak flow and breathlessness did not differ. Total and HDL cholesterol fell over the 4 weeks with both cookie types (both p < 0.001) and vital capacity rose 5 percent, but there was no buckwheat-free control. The authors declared no conflicts; no funding source is stated.
  2. Qiu J, Liu Y, Yue Y, Qin Y, Li Z. Dietary tartary buckwheat intake attenuates insulin resistance and improves lipid profiles in patients with type 2 diabetes: a randomized controlled trial. Nutr Res. 2016;36(12):1392-1401. doi: 10.1016/j.nutres.2016.11.007.PubMedUsed to support: Parallel, randomized, open-label controlled trial in 165 adults with type 2 diabetes in China. The control group received systematic diet plans and intensive nutritional education; the tartary buckwheat group replaced part of its daily staple food with tartary buckwheat foods for 4 weeks. Compared with the control group, fasting insulin, total cholesterol (5.08 to 4.79 mmol/L) and LDL cholesterol (3.00 to 2.80 mmol/L) fell more (P < .05). Blood glucose and HbA1c did not differ between groups. In subgroup analyses, insulin resistance also fell when intake exceeded 110 g a day. Read as abstract only; funding and registration are not given in the abstract.
  3. Qiu J, Li Z, Qin Y, Yue Y, Liu Y. Protective effect of tartary buckwheat on renal function in type 2 diabetics: a randomized controlled trial. Ther Clin Risk Manag. 2016;12:1721-1727. doi: 10.2147/TCRM.S123008.PubMedUsed to support: Parallel, randomized, open-label 4-week trial in 104 adults with type 2 diabetes (diabetes for 5 to 20 years, eGFR at least 90), registered ChiCTR-IIR-15007600. The control group ate white rice or wheat flour as daily cereals with intensive nutrition education; the tartary buckwheat group replaced part of the rice and wheat with energy-matched tartary buckwheat noodles, cooked grain or powder (about 100 g a day; average 114 g), supplied free by Guiyang Winner Hi-Tech Development Co. Compared with control, the urine albumin to creatinine ratio (p = 0.032) and blood urea nitrogen (p = 0.028) fell more; serum creatinine, uric acid, eGFR, blood pressure, fasting glucose, HbA1c and glycated albumin did not differ. Protein intake rose in the buckwheat group only. Funded by the Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences and the China Agriculture Research System; the authors report no conflicts.
  4. Nishimura M, Ohkawara T, Sato Y, Satoh H, Suzuki T, Ishiguro K, Noda T, Morishita T, Nishihira J. Effectiveness of rutin-rich Tartary buckwheat (Fagopyrum tataricum Gaertn.) 'Manten-Kirari' in body weight reduction related to its antioxidant properties: A randomised, double-blind, placebo-controlled study J Funct Foods. 2016;26:460-469. doi: 10.1016/j.jff.2016.08.004.SourceUsed to support: Not PubMed-indexed; abstract read, full text not accessible. Crossref lists funding from a NARO (National Agriculture and Food Research Organization, Japan) health-food development program, and four co-authors are NARO researchers from the team that developed Manten-Kirari. Randomized double-blind placebo-controlled trial in 144 adults comparing products made with rutin-rich Manten-Kirari tartary buckwheat against placebo foods for 12 weeks, with measurements again 3 weeks after stopping. The atherosclerosis index and oxidized LDL did not differ between groups. TBARS (a lipid oxidation marker), body weight and BMI were lower than placebo at week 8, and body fat percentage at week 4. A 2022 systematic review (Llanaj et al.) lists the comparator as wheat-based noodles and cookies and reports no effect on BMI or body fat, and no lasting change in oxidized LDL or TBARS, at the end of the 12 weeks.
  5. Wang Y, Chen L, Yao L, Guo R, Chen Y, Shi R. A study on the effects of a whole grain diet combined with short duration exercise on postprandial glucose levels in overweight and obese adults. Front Nutr. 2026;13:1886129. doi: 10.3389/fnut.2026.1886129.PubMedUsed to support: Within-subject, fixed-sequence study in 43 adults with overweight or obesity who ate five commercial grain powders, each for 3 days, as breakfast with a boiled egg while wearing glucose monitors; tartary buckwheat flour came first. The tartary buckwheat meal (70 g with the egg, 13.5 g carbohydrate) gave the highest 2-hour blood glucose and the largest glucose variability of the five powders; its incremental glucose area was similar to millet and oat and higher than soy milk powder. The meals were not matched for carbohydrate or energy, and the authors list nutrient differences as confounders. Authors declared no commercial conflicts.
  6. Llanaj E, Ahanchi NS, Dizdari H, Taneri PE, Niehot CD, Wehrli F, Khatami F, Raeisi-Dehkordi H, Kastrati L, Bano A, Glisic M, Muka T. Buckwheat and Cardiometabolic Health: A Systematic Review and Meta-Analysis. J Pers Med. 2022;12(12):1940. doi: 10.3390/jpm12121940.PubMedUsed to support: Systematic review of 16 human studies (831 participants) of buckwheat or its compounds, including the tartary buckwheat trials of Wieslander, Qiu and Nishimura and older Chinese tartary buckwheat studies. Pooled across 8 studies (464 participants), buckwheat did not significantly change total cholesterol (-0.14 mmol/L, 95 percent CI -0.30 to 0.02), LDL, HDL, triglycerides, body weight or glucose (-0.18 mmol/L, 95 percent CI -0.36 to 0.003), with high heterogeneity and risk-of-bias concerns in most studies. The authors note that tartary buckwheat claims rest largely on laboratory and animal models and that two tartary trials found no effect on HbA1c. One author received fees from Standard Process, which paid the publication fee.
  7. Fabjan N, Rode J, Kosir IJ, Wang Z, Zhang Z, Kreft I. Tartary buckwheat (Fagopyrum tataricum Gaertn.) as a source of dietary rutin and quercitrin. J Agric Food Chem. 2003;51(22):6452-5. doi: 10.1021/jf034543e.PubMedUsed to support: HPLC analysis of tartary buckwheat from China and Luxembourg. Tartary buckwheat seeds contained about 0.8 to 1.7 percent rutin by dry weight, against about 0.01 percent in common buckwheat seeds, and the herb up to 3 percent. Tartary seeds also had traces of quercitrin and quercetin, not found in common buckwheat seeds. Content depended on variety and growing conditions. Composition data, not a study in people.
  8. Suzuki T, Morishita T, Mukasa Y, Takigawa S, Yokota S, Ishiguro K, Noda T. Discovery and genetic analysis of non-bitter Tartary buckwheat (Fagopyrum tataricum Gaertn.) with trace-rutinosidase activity. Breed Sci. 2014;64(4):339-43. doi: 10.1270/jsbbs.64.339.PubMedUsed to support: Screening of about 500 tartary buckwheat lines found lines with only trace rutinosidase, the seed enzyme that breaks down rutin, a trait inherited as a single recessive gene. Sensory panelists found strong bitterness in flour from normal-enzyme plants and none in flour from trace-enzyme plants, indicating that rutin breakdown is the main source of the bitterness. Plant breeding work, not a study of health effects.
  9. Suzuki T, Morishita T, Noda T, Ishiguro K, Otsuka S, Katsu K. Breeding of Buckwheat to Reduce Bitterness and Rutin Hydrolysis. Plants (Basel). 2021;10(4):791. doi: 10.3390/plants10040791.PubMedUsed to support: Review from Japan's National Agriculture and Food Research Organization. Tartary buckwheat seeds contain large amounts of rutin together with rutinosidase, which can hydrolyze flour rutin within several minutes after water is added; in dough from a normal variety, rutin was completely hydrolyzed within 10 minutes. The trace-rutinosidase variety Manten-Kirari kept more rutin in breads, cakes and noodles and was not rated bitter, while 27 of 29 panelists found the normal variety strongly bitter. Common buckwheat grains contain about 10 to 30 mg rutin per 100 g dry weight. Composition and breeding data only.
  10. Norbäck D, Wieslander G. A Review on Epidemiological and Clinical Studies on Buckwheat Allergy. Plants (Basel). 2021;10(3):607. doi: 10.3390/plants10030607.PubMedUsed to support: Review of PubMed literature from 1970 to 2020. Buckwheat, covering both common and tartary buckwheat, can cause IgE-mediated allergy, including severe reactions and anaphylaxis, through eating it, handling it at work or sleeping on buckwheat husk pillows. Allergenic proteins have been identified in both species (for tartary buckwheat, Fag t 1, Fag t 2 and Fag t 3). Cross-reactivity with peanut, latex, coconut, quinoa and poppy seed has been described. Estimated population prevalence is 0.1 to 0.4 percent in Japan, Korea and buckwheat-eating areas of China; severe reactions are rare.
  11. Kajita N, Yoshida K. Buckwheat Allergy in Asia. Curr Allergy Asthma Rep. 2024;24(9):549-557. doi: 10.1007/s11882-024-01166-6.PubMedUsed to support: Review describing buckwheat allergy as a significant issue in Asia, covering immediate food allergy, food-dependent exercise-induced anaphylaxis and food protein-induced enterocolitis syndrome. Seven components of common buckwheat and four of tartary buckwheat have been implicated in buckwheat allergy.
  12. Perlmutter A, Bland JS, Chandra A, Malani SS, Smith R, Mendez TL, Dwaraka VB. The impact of a polyphenol-rich supplement on epigenetic and cellular markers of immune age: a pilot clinical study. Front Nutr. 2024;11:1474597. doi: 10.3389/fnut.2024.1474597.PubMedUsed to support: Single-arm, open-label 90-day study (NCT05234203) in 50 healthy adults, 40 in the final analysis, of HTB Rejuvenate, a multi-ingredient capsule described as based on tartary buckwheat. The daily dose of four capsules contained 190 mg of Himalayan tartary buckwheat flour, together with 1,158 mg of polyphenols (mainly quercetin, with rutin, hesperidin and luteolin), 300 mg D-chiro-inositol, 2-HOBA, HMB, chlorophyllin, vitamin C and calcium. Changes in epigenetic age clocks and estimated immune cell types were reported without a placebo group. Funded by the maker, Big Bold Health, which employed two authors; it does not test tartary buckwheat itself.
  13. Ryu JY, Choi Y, Hong KH, Chung YS, Cho SK. Effect of Roasting and Brewing on the Antioxidant and Antiproliferative Activities of Tartary Buckwheat. Foods. 2020;9(9):1331. doi: 10.3390/foods9091331.PubMedUsed to support: Laboratory study of tartary buckwheat, described as widely used in infusion teas. Grain roasted at 210 C for 10 minutes and brewed at room temperature for 24 hours gave the highest total polyphenol and flavonoid content and the strongest radical-scavenging activity of the four teas tested, and rutin was the main contributor to that activity. Test-tube work only.
  14. Yao Y, Shan F, Bian J, Chen F, Wang M, Ren G. D-chiro-inositol-enriched tartary buckwheat bran extract lowers the blood glucose level in KK-Ay mice. J Agric Food Chem. 2008;56(21):10027-31. doi: 10.1021/jf801879m.PubMedUsed to support: Animal study. D-chiro-inositol in tartary buckwheat bran extract was enriched from 0.03 percent to 0.22 percent by steaming and to 22 percent by further purification. In diabetic KK-Ay mice, the enriched extract lowered plasma glucose, C-peptide, glucagon, triglycerides and blood urea nitrogen and improved glucose tolerance; its LD50 in mice exceeded 20 g/kg. Not tested in people.
  15. Suzuki T, Morishita T, Noda T, Ishiguro K. Acute and Subacute Toxicity Studies on Rutin-Rich Tartary Buckwheat Dough in Experimental Animals. J Nutr Sci Vitaminol (Tokyo). 2015;61(2):175-81. doi: 10.3177/jnsv.61.175.PubMedUsed to support: Rat toxicity studies of dough from the rutin-rich variety Manten-Kirari. A single 10,000 mg/kg flour dose caused no toxic signs or deaths. In the subacute study at 5,000 mg flour/kg, body weight and food intake did not differ from controls, and the tissue findings seen occurred at similar rates in the Manten-Kirari, common buckwheat and control groups; the authors set 5,000 mg flour/kg as a no-effect level. Animal data only.
  16. Podolska G, Gujska E, Klepacka J, Aleksandrowicz E. Bioactive Compounds in Different Buckwheat Species. Plants (Basel). 2021;10(5):961. doi: 10.3390/plants10050961.PubMedUsed to support: Two-year field comparison in Poland of two tartary buckwheat cultivars and four common buckwheat cultivars or forms. Tartary buckwheat grain had more total phenolic acids, rutin and calcium, while common buckwheat had more protein, copper, manganese and magnesium. Composition data only.